iShares Biotechnology ETF
399 hedge funds and large institutions have $6.62B invested in iShares Biotechnology ETF in 2015 Q1 according to their latest regulatory filings, with 70 funds opening new positions, 144 increasing their positions, 113 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
399
Holders Change
+30
Holders Change %
+8.13%
% of All Funds
10.64%
Holding in Top 10
33
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+32%
% of All Funds
0.88%
New
70
Increased
144
Reduced
113
Closed
37
Calls
$479M
Puts
$1.09B
Net Calls
-$610M
Net Calls Change
-$237M
Top Buyers
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
+$584M |
| 2 |
Goldman Sachs
New York
|
+$290M |
| 3 |
JPMorgan Chase & Co
New York
|
+$206M |
| 4 |
Citigroup
New York
|
+$130M |
| 5 |
Morgan Stanley
New York
|
+$86.5M |
Top Sellers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$467M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$142M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$128M |
| 4 |
Barclays
London,
United Kingdom
|
-$104M |
| 5 |
Jane Street
New York
|
-$41.1M |
